News & Updates
Filter by Specialty:
Haemorrhagic complications in COVID-19 patients linked to in-ICU mortality risk
A large global study of patients with severe COVID-19 admitted to the intensive care unit (ICU) has shown a 14 percent prevalence of haemorrhagic, coagulopathic, and thrombotic (HECTOR) complications in these patients, with mortality risk increased in those with haemorrhagic complications.
Haemorrhagic complications in COVID-19 patients linked to in-ICU mortality risk
16 Aug 2022Investigational nasal spray for dry eye disease scores high in phase II trial
The single-dose nicotinic acetylcholine receptor agonist OC-02, administered as an aqueous nasal spray, helps increase tear production and improve eye dryness in patients with dry eye disease (DED), according to data from the phase II PEARL trial.
Investigational nasal spray for dry eye disease scores high in phase II trial
16 Aug 2022PLWH at a disadvantage in receiving statin therapy for ASCVD risk reduction
People living with HIV (PLWH) are less likely to receive appropriate statin therapy for the prevention of atherosclerotic cardiovascular disease (ASCVD), a study has found.
PLWH at a disadvantage in receiving statin therapy for ASCVD risk reduction
16 Aug 2022How effective is ensovibep in hospitalized adults with COVID-19?
Hospitalized patients with COVID-19 who are receiving remdesivir and other standard care show no improvements in clinical outcomes with the addition of ensovibep, according to the results of a study.
How effective is ensovibep in hospitalized adults with COVID-19?
16 Aug 2022
Does TB influence viral suppression in HIV patients on DTG-based therapy?
Incident tuberculosis (TB) appears to be a risk factor for virologic non-suppression (ie, viral load of >1,000 copies/mL) in HIV patients who have transitioned to dolutegravir (DTG)-based therapy with recycled NRTIs*, according to a retrospective subanalysis of the VISEND study.
